Kasabach-Merritt syndrome: coagulo--analytical observations.
D000328:Adult; D001772:Blood Cell Count; D001777:Blood Coagulation; D001780:Blood Coagulation Tests; D001792:Blood Platelets; D004211:Disseminated Intravascular Coagulation / Q000150:complications; D005165:Factor V / Q000032:analysis; D005169:Factor VIII / Q000032:analysis; D005340:Fibrinogen / Q000032:analysis; D005342:Fibrinolysis; D006391:Hemangioma / Q000097:blood / Q000150:complications / Q000151:congenital* / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D006493:Heparin / Q000008:administration & dosage; D006801:Humans; D008297:Male; D010958:Plasminogen / Q000032:analysis; D010973:Platelet Adhesiveness; D011183:Postoperative Complications; D011516:Prothrombin / Q000032:analysis; D011696:Purpura, Thrombocytopenic / Q000097:blood / Q000150:complications / Q000151:congenital* / Q000188:drug therapy; D012878:Skin Neoplasms / Q000097:blood / Q000150:complications / Q000151:congenital* / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D013916:Thrombelastography; D013927:Thrombosis / Q000209:etiology
D005165:Factor V; D011516:Prothrombin; D005169:Factor VIII; D005340:Fibrinogen; D010958:Plasminogen; D006493:Heparin